Oseltamivir Stada (Oseltamivir)

Oseltamivir is a neuraminidase inhibitor. After oral administration, it is converted to its active form, which binds to the viral neuraminidase enzyme, blocking the release of new viral particles from infected cells and thereby limiting the spread of influenza within the respiratory tract.

The dosing regimen for Oseltamivir Stada is determined by the prescribing healthcare professional based on the patient’s age, weight, renal function, and the indication (treatment or prophylaxis). Patients should follow the prescriber’s instructions and the product label.

Oseltamivir may be used during pregnancy only if the potential benefits justify any potential risk to the fetus. It is excreted in breast milk in small amounts; breastfeeding mothers should discuss risks and benefits with their healthcare provider before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Oseltamivir is a neuraminidase inhibitor, similar to zanamivir and peramivir, but is administered orally, offering convenient dosing compared with inhaled or intravenous alternatives. Its efficacy in reducing flu symptom duration is comparable, while safety profiles are generally similar across the class.

Oseltamivir Stada should be stored at room temperature, below 25 °C. Keep the capsules in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Oseltamivir Stada is taken orally, usually with or without food, as directed by a healthcare professional. The capsules should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

Serious risks include severe allergic reactions such as anaphylaxis, rare neuropsychiatric events like confusion or abnormal behavior, and rare skin reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience any of these symptoms.

Oseltamivir Stada should be avoided in individuals with a known hypersensitivity to oseltamivir or any of the product’s excipients. Caution is also advised for patients with severe renal impairment, and it should not be used without medical supervision in such cases.